Summary of Methodologies in Place for International Normalized Ratio Testing in New South Wales Health Pathology “West” and “Rural/Regional” Laboratories
Characteristic . | Instruments in use . | PT reagents in use . | Total different combinations (reagent/instrument) . |
---|---|---|---|
Prechange over (2017-2019) | Stago: STA-Satellite ×23; STA-Compact Max ×10; STA-R Evolution ×2 | Stago: Neoplastine CI Plus, then NeoPTimal, ×27 laboratories/35 instruments | Instrument manufacturers: n = 1 (Stago) Different instrument types: n = 3 (all Stago) Total instruments: n = 35 Different reagent types: n = 1 (all Neoplastine CI Plus then NeoPTimal) Different instrument/reagent combinations: n = 3 |
Postchange over (2021-2023) | Werfen: ACL TOP CTS 350 × 29; ACL TOP CTS 550 × 4; ACLTOP 750 CTS ×2 | Werfen: HemosIL RecombiPlasTin 2G ×27 laboratories/35 instruments | Instrument manufacturers: n = 1 (Werfen) Different instrument types: n = 3 (all Werfen) Total instruments: n = 35 Different reagent types: n = 1 (all HemosIL RecombiPlasTin 2G) Different instrument/reagent combinations: n = 3 |
Characteristic . | Instruments in use . | PT reagents in use . | Total different combinations (reagent/instrument) . |
---|---|---|---|
Prechange over (2017-2019) | Stago: STA-Satellite ×23; STA-Compact Max ×10; STA-R Evolution ×2 | Stago: Neoplastine CI Plus, then NeoPTimal, ×27 laboratories/35 instruments | Instrument manufacturers: n = 1 (Stago) Different instrument types: n = 3 (all Stago) Total instruments: n = 35 Different reagent types: n = 1 (all Neoplastine CI Plus then NeoPTimal) Different instrument/reagent combinations: n = 3 |
Postchange over (2021-2023) | Werfen: ACL TOP CTS 350 × 29; ACL TOP CTS 550 × 4; ACLTOP 750 CTS ×2 | Werfen: HemosIL RecombiPlasTin 2G ×27 laboratories/35 instruments | Instrument manufacturers: n = 1 (Werfen) Different instrument types: n = 3 (all Werfen) Total instruments: n = 35 Different reagent types: n = 1 (all HemosIL RecombiPlasTin 2G) Different instrument/reagent combinations: n = 3 |
PT, prothrombin time.
Summary of Methodologies in Place for International Normalized Ratio Testing in New South Wales Health Pathology “West” and “Rural/Regional” Laboratories
Characteristic . | Instruments in use . | PT reagents in use . | Total different combinations (reagent/instrument) . |
---|---|---|---|
Prechange over (2017-2019) | Stago: STA-Satellite ×23; STA-Compact Max ×10; STA-R Evolution ×2 | Stago: Neoplastine CI Plus, then NeoPTimal, ×27 laboratories/35 instruments | Instrument manufacturers: n = 1 (Stago) Different instrument types: n = 3 (all Stago) Total instruments: n = 35 Different reagent types: n = 1 (all Neoplastine CI Plus then NeoPTimal) Different instrument/reagent combinations: n = 3 |
Postchange over (2021-2023) | Werfen: ACL TOP CTS 350 × 29; ACL TOP CTS 550 × 4; ACLTOP 750 CTS ×2 | Werfen: HemosIL RecombiPlasTin 2G ×27 laboratories/35 instruments | Instrument manufacturers: n = 1 (Werfen) Different instrument types: n = 3 (all Werfen) Total instruments: n = 35 Different reagent types: n = 1 (all HemosIL RecombiPlasTin 2G) Different instrument/reagent combinations: n = 3 |
Characteristic . | Instruments in use . | PT reagents in use . | Total different combinations (reagent/instrument) . |
---|---|---|---|
Prechange over (2017-2019) | Stago: STA-Satellite ×23; STA-Compact Max ×10; STA-R Evolution ×2 | Stago: Neoplastine CI Plus, then NeoPTimal, ×27 laboratories/35 instruments | Instrument manufacturers: n = 1 (Stago) Different instrument types: n = 3 (all Stago) Total instruments: n = 35 Different reagent types: n = 1 (all Neoplastine CI Plus then NeoPTimal) Different instrument/reagent combinations: n = 3 |
Postchange over (2021-2023) | Werfen: ACL TOP CTS 350 × 29; ACL TOP CTS 550 × 4; ACLTOP 750 CTS ×2 | Werfen: HemosIL RecombiPlasTin 2G ×27 laboratories/35 instruments | Instrument manufacturers: n = 1 (Werfen) Different instrument types: n = 3 (all Werfen) Total instruments: n = 35 Different reagent types: n = 1 (all HemosIL RecombiPlasTin 2G) Different instrument/reagent combinations: n = 3 |
PT, prothrombin time.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.